NFKB1 and ovarian carcinoma: It is tempting to speculate that a possible mechanism by which ovarian cancer cells stimulated by COL11A1 maintain resistance to cisplatin involves upregulation of total and phosphorylated HSP27, which in turn activates NFkB and subsequentially leads to an increase in IAP expression.